Arsenal Capital Partners

Arsenal Capital Partners is a New York-based private equity firm that builds platforms in two industries: healthcare and specialty industrials. On the healthcare side, its focus is pharma and therapeutics services and life sciences tools, where it tends to assemble multi-asset platforms by combining a control acquisition with subsequent add-ons. Arsenal is not described as AI-focused in the source data.

Check sizes start at $25M and run higher for platform deals. Deployment is primarily in the United States, with selective international exposure tied to portfolio company expansion. Specific named portfolio companies in the healthcare AI category are not provided in the source data.

For healthcare AI founders, Arsenal becomes relevant only at later stages, typically when a company has crossed meaningful revenue scale and either fits as a platform anchor or as an add-on to an existing Arsenal portfolio company. Early-stage AI founders should not pitch directly. The most productive path in is via a banker-led process or as a strategic add-on to a current portfolio platform.